Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

Vaccines Against Potential Pandemic Strains Of Influenza

  • Read more about Vaccines Against Potential Pandemic Strains Of Influenza
Australia
2007286161
Filed on 2007-08-09

Use Of HIV Mosiac Envelope Proteins To Optimize T Cell Responses Against HIV Envelope

  • Read more about Use Of HIV Mosiac Envelope Proteins To Optimize T Cell Responses Against HIV Envelope
Patent Cooperation Treaty
PCT/US2009/060167
Filed on 2009-10-09

Insect Salivary Proteins, Particularly Sand Fly Salivary Proteins Work As Non-classical Natural Adjuvants Driving A Specific Immune Response That Accelerate The Immune Response To Another Protein Or Pathogen

  • Read more about Insect Salivary Proteins, Particularly Sand Fly Salivary Proteins Work As Non-classical Natural Adjuvants Driving A Specific Immune Response That Accelerate The Immune Response To Another Protein Or Pathogen
Patent Cooperation Treaty
PCT/US2009/053941
Filed on 2009-08-14

Device and Methods for Microwave-Assisted Cryo-Sample Processing

  • Read more about Device and Methods for Microwave-Assisted Cryo-Sample Processing
Patent Cooperation Treaty
PCT/US2009/055913
Filed on 2009-09-03

Method For Boosting Immunity To Influenza Vaccine

  • Read more about Method For Boosting Immunity To Influenza Vaccine
Patent Cooperation Treaty
PCT/US2009/58464
Filed on 2009-09-25

A Novel Deletion In The Human Parainfluenze Type 1 (HPIV1) L Gene, Of Amino Acids 1710-1711, Attenuates In Vitro And In Vivo And Is A Promising Mutation For Inclusion In Future HPIV1 Vaccine Candidates

  • Read more about A Novel Deletion In The Human Parainfluenze Type 1 (HPIV1) L Gene, Of Amino Acids 1710-1711, Attenuates In Vitro And In Vivo And Is A Promising Mutation For Inclusion In Future HPIV1 Vaccine Candidates
Patent Cooperation Treaty
PCT/US2009/049461
Filed on 2009-07-01

Plasmodial Surface Anion Channel Antagonists As Lead Molecules For Antimalarial Drug Development

  • Read more about Plasmodial Surface Anion Channel Antagonists As Lead Molecules For Antimalarial Drug Development
Patent Cooperation Treaty
PCT/US09/50637
Filed on 2009-07-15

Use Of Mono-Amine Oxidase Inhibitors To Prevent Herpes Simpex Virus Infection And Reactiviation From Latency

  • Read more about Use Of Mono-Amine Oxidase Inhibitors To Prevent Herpes Simpex Virus Infection And Reactiviation From Latency
Patent Cooperation Treaty
PCT/US2009/051557
Filed on 2009-07-23

Method of Using Adenoviral Vectors to Induce an Immune Response

  • Read more about Method of Using Adenoviral Vectors to Induce an Immune Response
US Application 12/477,712
Filed on 2009-06-03

METHOD FOR IDENTIFICATION OF T-LYMPHOCYTE ANTIGENS

  • Read more about METHOD FOR IDENTIFICATION OF T-LYMPHOCYTE ANTIGENS
US Application 12/473,096
Filed on 2009-05-27

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 377
  • Page 378
  • Page 379
  • Page 380
  • Page 381
  • Page 382
  • Page 383
  • Page 384
  • Page 385
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health